ArticleJournal of neuro-oncology2015

Dendritic cell vaccination combined with temozolomide retreatment: results of a phase I trial in patients with recurrent glioblastoma multiforme.

Martin K Hunn et al.PubMed ↗Publisher ↗

No numbers read from the abstract.